Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Eli Lilly and Company Limited
Lilly House, Priestley Road, Basingstoke, Hampshire, RG24 9NL
Telephone: +44 (0)1256 315 000
Fax: +44 (0)1256 775 858
WWW: http://www.lilly.co.uk
Medical Information e-mail: ukmedinfo@lilly.com
Medical Information Fax: +44 (0)1256 775 569

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 03/11/2011
PIL Forsteo 20 micrograms/80 microlitres, solution for injection, in pre-filled pen

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 05/08/2011 and displayed until 03/11/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 01/08/2011 and displayed until 05/08/2011
Reasons for adding or updating:
  • Individual presentations superseded by joint PIL
Updated on 10/06/2011 and displayed until 01/08/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 16/06/2010 and displayed until 10/06/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change of manufacturer
  • Change to side-effects
Updated on 19/10/2009 and displayed until 16/06/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to side-effects
Updated on 02/07/2009 and displayed until 19/10/2009
Reasons for adding or updating:
  • Addition of separate PILs covering individual presentations
Updated on 20/03/2009 and displayed until 02/07/2009
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change due to harmonisation of PIL.
  • Change to date of revision
Updated on 30/04/2008 and displayed until 20/03/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
  • Changes to therapeutic indications
Updated on 05/12/2007 and displayed until 30/04/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 30/08/2007 and displayed until 05/12/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 20/08/2007 and displayed until 30/08/2007
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change of contra-indications
  • Change to information about drinking alcohol
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to instructions about overdose
  • Change to side-effects
  • Change to storage instructions
  • Change to Further Information section
  • Change to date of revision
Updated on 19/12/2005 and displayed until 20/08/2007
Reasons for adding or updating:
  • No reasons supplied
Updated on 23/07/2003 and displayed until 19/12/2005
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  teriparatide